CHRISTOPHER HAMANN: Open Payments
NPI 1790704054 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,051 in 43 payments from 16 companies in 2025. Trend: 2023 $1,099 · 2024 $797 · 2025 $1,051
Food & beverage: $1,051
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 13 | $360 |
| Ferring Pharmaceuticals Inc. | 4 | $106 |
| PFIZER INC. | 4 | $75 |
| TOLMAR, INC. | 3 | $72 |
| Antares Pharma, Inc. | 2 | $67 |
| Novo Nordisk Inc | 2 | $59 |
| COLOPLAST CORP | 2 | $47 |
| Endo USA, Inc. | 2 | $45 |
| Janssen Biotech, Inc. | 2 | $38 |
| ABBVIE INC. | 2 | $38 |
Products named: GEMTESA, ADSTILADRIN, Xtandi, JATENZO, XYOSTED, Rivfloza, SpeediCath, AVEED.
Industry payments across NY — which companies pay providers there.
